Selected article for: "activation signal and acute respiratory"

Author: Engin, Ayse Basak; Engin, Evren Doruk; Engin, Atilla
Title: The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2
  • Cord-id: dc6su38d
  • Document date: 2020_10_22
  • ID: dc6su38d
    Snippet: Many diverse strategies allow and facilitate severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) to evade antiviral innate immune mechanisms. Although the type I interferon (IFN) system has a critical role in restricting the dissemination of viral infection, suppression of IFN receptor signals by SARS-CoV-2 constitutes a checkpoint that plays an important role in the immune escape of the virus. Environmental pollution not only facilitates SARS-CoV-2 infection but also increases infe
    Document: Many diverse strategies allow and facilitate severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) to evade antiviral innate immune mechanisms. Although the type I interferon (IFN) system has a critical role in restricting the dissemination of viral infection, suppression of IFN receptor signals by SARS-CoV-2 constitutes a checkpoint that plays an important role in the immune escape of the virus. Environmental pollution not only facilitates SARS-CoV-2 infection but also increases infection-associated fatality risk, which arises due to Systemic Aryl hydrocarbon Receptor (AhR) Activation Syndrome. The intracellular accumulation of endogenous kynurenic acid due to overexpression of the indoleamine 2,3-dioxygenase (IDO) by AhR activation induces AhR-interleukin-6 (IL-6)- signal transducers and activators of the transcription 3 (STAT3) signaling pathway. The AhR-IDO1-Kynurenine pathway is an important checkpoint, which leads to fatal consequences in SARS-CoV-2 infection and immune evasion in the context of Treg/Th17 imbalance and cytokine storm.

    Search related documents:
    Co phrase search for related documents
    • ace activity and activity result: 1
    • ace activity and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • ace activity and lung tissue: 1, 2, 3, 4
    • activation syndrome and adp ribose: 1
    • activation syndrome and adp ribose polymerase: 1
    • activation syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activation syndrome and lung tissue: 1, 2, 3, 4, 5, 6
    • activation syndrome and lung tissue damage: 1, 2, 3
    • activator transducer and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • activator transducer and lung tissue: 1, 2, 3
    • activator transducer and lung tissue damage: 1
    • activity result and adp ribose: 1
    • activity result and lung injury: 1, 2, 3, 4
    • activity result and lung tissue: 1
    • adp ribose and lung injury: 1, 2, 3, 4, 5, 6
    • adp ribose and lung tissue: 1
    • adp ribose polymerase and lung injury: 1, 2, 3, 4, 5
    • adp ribose polymerase and lung tissue: 1
    • local defense and lung injury: 1